HRP20060401A2 - Piperazine derivatives of alkyl oxindoles - Google Patents

Piperazine derivatives of alkyl oxindoles

Info

Publication number
HRP20060401A2
HRP20060401A2 HR20060401A HRP20060401A HRP20060401A2 HR P20060401 A2 HRP20060401 A2 HR P20060401A2 HR 20060401 A HR20060401 A HR 20060401A HR P20060401 A HRP20060401 A HR P20060401A HR P20060401 A2 HRP20060401 A2 HR P20060401A2
Authority
HR
Croatia
Prior art keywords
piperazine derivatives
oxindoles
alkyl
alkyl oxindoles
derivatives
Prior art date
Application number
HR20060401A
Other languages
English (en)
Croatian (hr)
Inventor
Volk Bal�zs
Bark�czy J�zsef
Simig Gyula
Mezei Tibor
Kapillern� Dezsofi Rita
Gacs�lyi Istv�n
Pallagi Katalin
Gigler G�bor
L�vay Gy�rgy
M�ricz Krisztina
Leveleki Csilla
Sziray N�ra
Sz�n�si G�bor
Egyed Andr�s
G�bor H�rsing L�szl�
Original Assignee
Egis Gy�gyszergy�r Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0400954A external-priority patent/HU0400954D0/hu
Priority claimed from HU0500461A external-priority patent/HUP0500461A3/hu
Application filed by Egis Gy�gyszergy�r Nyrt. filed Critical Egis Gy�gyszergy�r Nyrt.
Publication of HRP20060401A2 publication Critical patent/HRP20060401A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
HR20060401A 2004-05-11 2006-11-20 Piperazine derivatives of alkyl oxindoles HRP20060401A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0400954A HU0400954D0 (en) 2004-05-11 2004-05-11 Piperazine derivatives of alkyl oxindoles
HU0500461A HUP0500461A3 (en) 2005-05-05 2005-05-05 Pyperazine derivatives of alkyl-oxindoles
PCT/HU2005/000048 WO2005108363A1 (en) 2004-05-11 2005-05-10 Piperazine derivatives of alkyl oxindoles

Publications (1)

Publication Number Publication Date
HRP20060401A2 true HRP20060401A2 (en) 2007-03-31

Family

ID=89985994

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20060401A HRP20060401A2 (en) 2004-05-11 2006-11-20 Piperazine derivatives of alkyl oxindoles
HR20090054T HRP20090054T3 (en) 2004-05-11 2009-01-29 Piperazine derivatives of alkyl oxindoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20090054T HRP20090054T3 (en) 2004-05-11 2009-01-29 Piperazine derivatives of alkyl oxindoles

Country Status (24)

Country Link
US (1) US20070219209A1 (de)
EP (1) EP1751106B1 (de)
JP (1) JP2007537226A (de)
KR (1) KR20070011551A (de)
AT (1) ATE412634T1 (de)
AU (1) AU2005240842B2 (de)
BG (1) BG109768A (de)
CA (1) CA2564009A1 (de)
CZ (1) CZ2006778A3 (de)
DE (1) DE602005010694D1 (de)
DK (1) DK1751106T3 (de)
EA (1) EA011280B1 (de)
ES (1) ES2317241T3 (de)
HR (2) HRP20060401A2 (de)
IL (1) IL178759A0 (de)
MX (1) MXPA06013064A (de)
NO (1) NO20065697L (de)
NZ (1) NZ551542A (de)
PL (1) PL1751106T3 (de)
PT (1) PT1751106E (de)
RS (1) RS20060620A (de)
SI (1) SI1751106T1 (de)
SK (1) SK51112006A3 (de)
WO (1) WO2005108363A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1776339E (pt) * 2004-05-11 2009-09-16 Egis Gyogyszergyar Nyrt Derivados de 3-(((4-fenil)-piperazin-1-il)-alquil)-3-alquil- 1,3-di-hidro-2h-indol-2-ona e compostos relacionados para o tratamento de desordens do sistema nervoso central
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes

Also Published As

Publication number Publication date
AU2005240842B2 (en) 2011-10-06
EA011280B1 (ru) 2009-02-27
US20070219209A1 (en) 2007-09-20
MXPA06013064A (es) 2007-04-27
DK1751106T3 (da) 2009-03-09
AU2005240842A1 (en) 2005-11-17
DE602005010694D1 (de) 2008-12-11
NO20065697L (no) 2007-02-02
PT1751106E (pt) 2009-02-10
EP1751106B1 (de) 2008-10-29
WO2005108363A1 (en) 2005-11-17
HRP20090054T3 (en) 2009-03-31
JP2007537226A (ja) 2007-12-20
CZ2006778A3 (cs) 2007-03-07
EP1751106A1 (de) 2007-02-14
SK51112006A3 (sk) 2007-05-03
NZ551542A (en) 2010-06-25
IL178759A0 (en) 2007-02-11
ES2317241T3 (es) 2009-04-16
PL1751106T3 (pl) 2009-07-31
ATE412634T1 (de) 2008-11-15
EA200602080A1 (ru) 2007-04-27
RS20060620A (en) 2008-09-29
CA2564009A1 (en) 2005-11-17
KR20070011551A (ko) 2007-01-24
SI1751106T1 (sl) 2009-06-30
BG109768A (bg) 2008-03-31

Similar Documents

Publication Publication Date Title
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
SE0201635D0 (sv) Novel compounds
EA201100749A1 (ru) Производные пиридина и пиримидина в качестве ингибиторов фосфодиэстеразы 10
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
MA30076B1 (fr) Carbonylaminopyrrolopyrazoles servant de puissants inhibiteurs de kinases.
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
TW200728258A (en) Novel compounds
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
EA201001481A1 (ru) Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
EA201000675A1 (ru) Производные хромана как модуляторы trpv3
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
DE502008002974D1 (de) ä Ä5- ( PHENYL) - 6- PHENYLPYRROLO Ä2,1-FÜÄ2,1, 4ÜTRIAZIN-4-YLÜAMINOü CARBONSÄUREDERIVATE UND VERWANDTE VERBINDUNGEN ALS PROSTAZYKLIN (PGI2) IP-REZEPTOR AKTIVATOREN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN
HRP20060402A2 (en) Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
HRP20060401A2 (en) Piperazine derivatives of alkyl oxindoles
HRP20060420A2 (en) Piperazine derivatives of alkyl oxindoles
HRP20060404A2 (en) New piperazine derivatives of dialkyl oxindoles
HRP20060403A2 (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100419

Year of fee payment: 6

OBST Application withdrawn